Cerebrospinal Fluid (CSF) Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
NEW YORK, July 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0567529/Cerebrospinal-Fluid-CSF-Management-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
Cerebrospinal Fluid (CSF) Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Summary
GlobalData's new report, "Cerebrospinal Fluid (CSF) Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017" provides key market data on the Cerebrospinal Fluid (CSF) Management market in the BRICS countries. The report provides value (USD million), volume (units) and average price (USD) data for each segment within two market categories – Dura Substitutes and Hydrocephalus Shunts. The report also provides company shares and distribution shares data for the overall Cerebrospinal Fluid (CSF) Management market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.
The emerging economies, comprising of China, India, Brazil, Russia, and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that by 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Market size data for Cerebrospinal Fluid (CSF) Management market categories – Dura Substitutes and Hydrocephalus Shunts.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within the two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for the overall Cerebrospinal Fluid (CSF) Management market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Cerebrospinal Fluid (CSF) Management market in BRICS.
- Key players covered include Medtronic, Inc., Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Sophysa S.A.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Cerebrospinal Fluid (CSF) Management competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 12
2.1 What is This Report About? 12
3 CSF Management In BRICS 13
3.1 CSF Management, BRICS, Overall Revenue ($m), 2003-2017 13
3.2 CSF Management, BRICS, Category Volume (Units), 2003-2017 19
3.3 CSF Management, BRICS, Company Share (2009-2010) 23
4 CSF Management In Brazil 25
4.1 CSF Management, Brazil, Overall Revenue (2003-2017) 25
4.2 CSF Management, Brazil Overall Volume (2003-2017) 29
4.3 Dura Substitutes in Brazil 32
4.3.1 Dura Substitutes, Brazil, Overall Revenue (2003-2017) 32
4.3.2 Dura Substitutes, Brazil, Overall Volume (2003-2017) 34
4.3.3 Dura Substitutes, Brazil, Average, Price (2003-2017) 36
4.4 Hydrocephalus Shunts in Brazil 37
4.4.1 Hydrocephalus Shunts, Brazil, Overall Revenue (2003-2017) 37
4.4.2 Hydrocephalus Shunts, Brazil, Overall Volume (2003-2017) 39
4.4.3 Hydrocephalus Shunts, Brazil, Average, Price (2003-2017) 41
4.5 CSF Management, Brazil, Distribution Share (2009-2010) 42
4.6 CSF Management, Brazil, Company Share (2009-2010) 43
5 CSF Management In Russian Federation 45
5.1 CSF Management, Russian Federation, Overall Revenue (2003-2017) 45
5.2 CSF Management, Russian Federation, Overall Volume (2003-2017) 49
5.3 Dura Substitutes In Russian Federation 53
5.3.1 Dura Substitutes, Russian Federation, Overall Revenue (2003-2017) 53
5.3.2 Dura Substitutes, Russian Federation, Overall Volume (2003-2017) 55
5.3.3 Dura Substitutes, Russian Federation, Average, Price (2003-2017) 57
5.4 Hydrocephalus Shunts in Russian Federation 58
5.4.1 Hydrocephalus Shunts, Russian Federation, Overall Revenue (2003-2017) 58
5.4.2 Hydrocephalus Shunts, Russian Federation, Overall Volume (2003-2017) 60
5.4.3 Hydrocephalus Shunts, Russian Federation, Average, Price (2003-2017) 62
5.5 CSF Management, Russian Federation, Distribution Share (2009-2010) 63
5.6 CSF Management, Russian Federation, Company Share (2009-2010) 64
6 CSF Management In India 65
6.1 CSF Management, India, Overall Revenue (2003-2017) 65
6.2 CSF Management, India, Overall Volume (2003-2017) 70
6.3 Dura Substitutes in India 73
6.3.1 Dura Substitutes, India, Overall Revenue (2003-2017) 73
6.3.2 Dura Substitutes, India, Overall Volume (2003-2017) 75
6.3.3 Dura Substitutes, India, Average, Price (2003-2017) 77
6.4 Hydrocephalus Shunts in India 78
6.4.1 Hydrocephalus Shunts, India, Overall Revenue (2003-2017) 78
6.4.2 Hydrocephalus Shunts, India, Overall Volume (2003-2017) 80
6.4.3 Hydrocephalus Shunts, India, Average, Price (2003-2017) 82
6.5 CSF Management, India, Distribution Share (2009-2010) 83
6.6 CSF Management, India, Company Share (2009-2010) 84
7 CSF Management In China 85
7.1 CSF Management, China, Overall Revenue (2003-2017) 85
7.2 CSF Management, China, Overall Volume (2003-2017) 90
7.3 Dura Substitutes in China 93
7.3.1 Dura Substitutes, China, Overall Revenue (2003-2017) 93
7.3.2 Dura Substitutes, China, Overall Volume (2003-2017) 95
7.3.3 Dura Substitutes, China, Average, Price (2003-2017) 97
7.4 Hydrocephalus Shunts in China 98
7.4.1 Hydrocephalus Shunts, China, Overall Revenue (2003-2017) 98
7.4.2 Hydrocephalus Shunts, China, Overall Volume (2003-2017) 100
7.4.3 Hydrocephalus Shunts, China, Average, Price (2003-2017) 102
7.5 CSF Management, China, Distribution Share (2009-2010) 103
7.6 CSF Management, China, Company Share (2009-2010) 104
8 CSF Management In South Africa 106
8.1 CSF Management, South Africa, Overall Revenue (2003-2017) 106
8.2 CSF Management, South Africa, Overall Volume (2003-2017) 109
8.3 Dura Substitutes in South Africa 112
8.3.1 Dura Substitutes, South Africa, Overall Revenue (2003-2017) 112
8.3.2 Dura Substitutes, South Africa, Overall Volume (2003-2017) 114
8.3.3 Dura Substitutes, South Africa, Average, Price (2003-2017) 116
8.4 Hydrocephalus Shunts in South Africa 117
8.4.1 Hydrocephalus Shunts, South Africa, Overall Revenue (2003-2017) 117
8.4.2 Hydrocephalus Shunts, South Africa, Overall Volume (2003-2017) 119
8.4.3 Hydrocephalus Shunts, South Africa, Average, Price (2003-2017) 121
8.5 CSF Management, South Africa, Distribution Share (2009-2010) 122
8.6 CSF Management, South Africa, Company Share (2009-2010) 123
9 Overview of Key Companies in BRICS CSF Management Market 125
9.1 Medtronic, Inc. 125
9.1.1 Company Overview 125
9.1.2 Share in the BRICS CSF Management Market 126
9.2 Integra LifeSciences Holdings Corporation 127
9.2.1 Company Overview 127
9.2.2 Share in the BRICS CSF Management Market 128
9.3 B. Braun Melsungen AG 129
9.3.1 Company Overview 129
9.3.2 Share in the BRICS CSF Management Market 130
9.4 Sophysa S.A. 131
9.4.1 Company Overview 131
9.4.2 Share in the BRICS CSF Management Market 132
10 Appendix 133
10.1 Definitions of Markets Covered in the Report 134
10.1.1 CSF Management 134
10.2 Research Methodology 135
10.3 Secondary Research 135
10.4 Primary Research 136
10.5 Models 136
10.6 Forecasts 137
10.7 Expert Panels 137
10.8 GlobalData Consulting 137
10.9 Currency Conversion 137
10.10 Contact Us 138
10.11 Disclaimer 138
1.1
List of Tables
Table 1: CSF Management, BRICS, Overall Revenue ($m), 2003-2017 14
Table 2: CSF Management, BRICS, Overall Revenue ($m), Historic, 2003-2010 16
Table 3: CSF Management, BRICS, Overall Revenue ($m), Forecast, 2010-2017 18
Table 4: CSF Management, BRICS, Category Volume (Units), 2003-2017 19
Table 5: CSF Management, BRICS, Category Volume (Units), Historic, 2003-2010 21
Table 6: CSF Management, BRICS, Category Volume (Units), Forecast, 2010-2017 22
Table 7: CSF Management, BRICS, Company Share by Revenue ($m), 2009-2010 24
Table 8: CSF Management, Brazil, Overall Revenue ($m), 2003-2017 25
Table 9: CSF Management, Brazil, Revenue ($m), Historic, 2003-2010 26
Table 10: CSF Management, Brazil, Revenue ($m), Forecast, 2010-2017 28
Table 11: CSF Management, Brazil, Overall Volume (Units) 2003-2017 29
Table 12: CSF Management, Brazil, Volume (Units), Historic, 2003-2010 30
Table 13: CSF Management, Brazil, Volume (Units), Forecast, 2010-2017 31
Table 14: Dura Substitutes, Brazil, Revenue ($m), Historic, 2003-2010 32
Table 15: Dura Substitutes, Brazil, Revenue ($m), Forecast, 2010-2017 33
Table 16: Dura Substitutes, Brazil, Volume (Units), Historic, 2003-2010 34
Table 17: Dura Substitutes, Brazil, Volume (Units), Forecast, 2010-2017 35
Table 18: Dura Substitutes, Brazil, Average Price ($), Historic, 2003-2010 36
Table 19: Dura Substitutes, Brazil, Average Price ($), Forecast, 2010-2017 36
Table 20: Hydrocephalus Shunts, Brazil, Revenue ($m), Historic, 2003-2010 37
Table 21: Hydrocephalus Shunts, Brazil, Revenue ($m), Forecast, 2010-2017 38
Table 22: Hydrocephalus Shunts, Brazil, Volume (Units), Historic, 2003-2010 39
Table 23: Hydrocephalus Shunts, Brazil, Volume (Units), Forecast, 2010-2017 40
Table 24: Hydrocephalus Shunts, Brazil, Average Price ($), Historic, 2003-2010 41
Table 25: Hydrocephalus Shunts, Brazil, Average Price ($), Forecast, 2010-2017 41
Table 26: CSF Management, Brazil, Distribution Share by Revenue ($m), 2009-2010 42
Table 27: CSF Management, Brazil, Company Share by Revenue ($m), 2009-2010 44
Table 28: CSF Management, Russian Federation, Overall Revenue ($m), 2003-2017 45
Table 29: CSF Management, Russian Federation, Revenue ($m), Historic, 2003-2010 47
Table 30: CSF Management, Russian Federation, Revenue ($m), Forecast, 2010-2017 48
Table 31: CSF Management, Russian Federation, Overall Volume (Units), 2003-2017 49
Table 32: CSF Management, Russian Federation, Volume (Units), Historic, 2003-2010 51
Table 33: CSF Management, Russian Federation, Volume (Units), Forecast, 2010-2017 52
Table 34: Dura Substitutes, Russian Federation, Revenue ($m), Historic, 2003-2010 53
Table 35: Dura Substitutes, Russian Federation, Revenue ($m), Forecast, 2010-2017 54
Table 36: Dura Substitutes, Russian Federation, Volume (Units), Historic, 2003-2010 55
Table 37: Dura Substitutes, Russian Federation, Volume (Units), Forecast, 2010-2017 56
Table 38: Dura Substitutes, Russian Federation, Average Price ($), Historic, 2003-2010 57
Table 39: Dura Substitutes, Russian Federation, Average Price ($), Forecast, 2010-2017 57
Table 40: Hydrocephalus Shunts, Russian Federation, Revenue ($m), Historic, 2003-2010 58
Table 41: Hydrocephalus Shunts, Russian Federation, Revenue ($m), Forecast, 2010-2017 59
Table 42: Hydrocephalus Shunts, Russian Federation, Volume (Units), Historic, 2003-2010 60
Table 43: Hydrocephalus Shunts, Russian Federation, Volume (Units), Forecast, 2010-2017 61
Table 44: Hydrocephalus Shunts, Russian Federation, Average Price ($), Historic, 2003-2010 62
Table 45: Hydrocephalus Shunts, Russian Federation, Average Price ($), Forecast, 2010-2017 62
Table 46: CSF Management, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 63
Table 47: CSF Management, Russian Federation, Company Share by Revenue ($m), 2009-2010 64
Table 48: CSF Management, India, Overall Revenue ($m), 2003-2017 65
Table 49: CSF Management, India, Revenue ($m), Historic, 2003-2010 67
Table 50: CSF Management, India, Revenue ($m), Forecast, 2010-2017 69
Table 51: CSF Management, India, Overall Volume (Units), 2003-2017 70
Table 52: CSF Management, India, Volume (Units), Historic, 2003-2010 71
Table 53: CSF Management, India, Volume (Units), Forecast, 2010-2017 72
Table 54: Dura Substitutes, India, Revenue ($m), Historic, 2003-2010 73
Table 55: Dura Substitutes, India, Revenue ($m), Forecast, 2010-2017 74
Table 56: Dura Substitutes, India, Volume (Units), Historic, 2003-2010 75
Table 57: Dura Substitutes, India, Volume (Units), Forecast, 2010-2017 76
Table 58: Dura Substitutes, India, Average Price ($), Historic, 2003-2010 77
Table 59: Dura Substitutes, India, Average Price ($), Forecast, 2010-2017 77
Table 60: Hydrocephalus Shunts, India, Revenue ($m), Historic, 2003-2010 78
Table 61: Hydrocephalus Shunts, India, Revenue ($m), Forecast, 2010-2017 79
Table 62: Hydrocephalus Shunts, India, Volume (Units), Historic, 2003-2010 80
Table 63: Hydrocephalus Shunts, India, Volume (Units), Forecast, 2010-2017 81
Table 64: Hydrocephalus Shunts, India, Average Price ($), Historic, 2003-2010 82
Table 65: Hydrocephalus Shunts, India, Average Price ($), Forecast, 2010-2017 82
Table 66: CSF Management, India, Distribution Share by Revenue ($m), 2009-2010 83
Table 67: CSF Management, India, Company Share by Revenue ($m), 2009-2010 84
Table 68: CSF Management, China, Overall Revenue ($m), 2003-2017 85
Table 69: CSF Management, China, Revenue ($m) by Historic, 2003-2010 87
Table 70: CSF Management, China, Revenue ($m), Forecast, 2010-2017 89
Table 71: CSF Management, China, Overall Volume (Units), 2003-2017 90
Table 72: CSF Management, China, Volume (Units), Historic, 2003-2010 91
Table 73: CSF Management, China, Volume (Units), Forecast, 2010-2017 92
Table 74: Dura Substitutes, China, Revenue ($m), Historic, 2003-2010 93
Table 75: Dura Substitutes, China, Revenue ($m), Forecast, 2010-2017 94
Table 76: Dura Substitutes, China, Volume (Units), Historic, 2003-2010 95
Table 77: Dura Substitutes, China, Volume (Units), Forecast, 2010-2017 96
Table 78: Dura Substitutes, China, Average Price ($), Historic, 2003-2010 97
Table 79: Dura Substitutes, China, Average Price ($), Forecast, 2010-2017 97
Table 80: Hydrocephalus Shunts, China, Revenue ($m), Historic, 2003-2010 98
Table 81: Hydrocephalus Shunts, China, Revenue ($m), Forecast, 2010-2017 99
Table 82: Hydrocephalus Shunts, China, Volume (Units), Historic, 2003-2010 100
Table 83: Hydrocephalus Shunts, China, Volume (Units), Forecast, 2010-2017 101
Table 84: Hydrocephalus Shunts, China, Average Price ($), Historic, 2003-2010 102
Table 85: Hydrocephalus Shunts, China, Average Price ($), Forecast, 2010-2017 102
Table 86: CSF Management, China, Distribution Share by Revenue ($m), 2009-2010 103
Table 87: CSF Management, China, Company Share by Revenue ($m), 2009-2010 105
Table 88: CSF Management, South Africa, Overall Revenue ($m), 2003-2017 106
Table 89: CSF Management, South Africa, Revenue ($m), Historic, 2003-2010 107
Table 90: CSF Management, South Africa, Revenue ($m), Forecast, 2010-2017 108
Table 91: CSF Management, South Africa, Overall Volume (Units), 2003-2017 109
Table 92: CSF Management, South Africa, Volume (Units), Historic, 2003-2010 110
Table 93: CSF Management, South Africa, Volume (Units), Forecast, 2010-2017 111
Table 94: Dura Substitutes, South Africa, Revenue ($m), Historic, 2003-2010 112
Table 95: Dura Substitutes, South Africa, Revenue ($m), Forecast, 2010-2017 113
Table 96: Dura Substitutes, South Africa, Volume (Units), Historic, 2003-2010 114
Table 97: Dura Substitutes, South Africa, Volume (Units), Forecast, 2010-2017 115
Table 98: Dura Substitutes, South Africa, Average Price ($), Historic, 2003-2010 116
Table 99: Dura Substitutes, South Africa, Average Price ($), Forecast, 2010-2017 116
Table 100: Hydrocephalus Shunts, South Africa, Revenue ($m), Historic, 2003-2010 117
Table 101: Hydrocephalus Shunts, South Africa, Revenue ($m), Forecast, 2010-2017 118
Table 102: Hydrocephalus Shunts, South Africa, Volume (Units), Historic, 2003-2010 119
Table 103: Hydrocephalus Shunts, South Africa, Volume (Units), Forecast, 2010-2017 120
Table 104: Hydrocephalus Shunts, South Africa, Average Price ($), Historic, 2003-2010 121
Table 105: Hydrocephalus Shunts, South Africa, Average Price ($), Forecast, 2010-2017 121
Table 106: CSF Management, South Africa, Distribution Share by Revenue ($m), 2009-2010 122
Table 107: CSF Management, South Africa, Company Share by Revenue ($m), 2009-2010 124
Table 108: Medtronic, Inc., Revenue ($m), BRICS CSF Management Market, 2010 126
Table 109: Integra LifeSciences Holdings Corporation, Revenue ($m), BRICS CSF Management Market, 2010 128
Table 110: B. Braun Melsungen AG, Revenue ($m), BRICS CSF Management Market, 2010 130
Table 111: Sophysa S.A., Revenue ($m), BRICS CSF Management Market, 2010 132
Table 112: USD to Local Currency, BRICS, Average Exchange Rate 2003-2010 137
1.2
List of Figures
Figure 1: CSF Management, BRICS, Overall Revenue ($m), 2003-2017 13
Figure 2: CSF Management, BRICS, Overall Revenue ($m), Historic, 2003-2010 15
Figure 3: CSF Management, BRICS, Overall Revenue ($m), Forecast, 2010-2017 17
Figure 4: CSF Management, BRICS, Category Volume (Units), 2003-2017 19
Figure 5: CSF Management, BRICS, Category Volume (Units), Historic, 2003-2010 20
Figure 6: CSF Management, BRICS, Category Volume (Units), Forecast, 2010-2017 22
Figure 7: CSF Management, BRICS, Company Share (%), 2010 23
Figure 8: CSF Management, Brazil, Overall Revenue ($m), 2003-2017 25
Figure 9: CSF Management, Brazil, Revenue ($m), Historic, 2003-2010 26
Figure 10: CSF Management, Brazil, Revenue ($m), Forecast, 2010-2017 27
Figure 11: CSF Management, Brazil, Overall Volume (Units), 2003-2017 29
Figure 12: CSF Management, Brazil, Volume (Units), Historic, 2003-2010 30
Figure 13: CSF Management, Brazil, Volume (Units), Forecast, 2010-2017 31
Figure 14: Dura Substitutes, Brazil, Revenue ($m), Historic, 2003-2010 32
Figure 15: Dura Substitutes, Brazil, Revenue ($m), Forecast, 2010-2017 33
Figure 16: Dura Substitutes, Brazil, Volume (Units), Historic, 2003-2010 34
Figure 17: Dura Substitutes, Brazil, Volume (Units), Forecast, 2010-2017 35
Figure 18: Hydrocephalus Shunts, Brazil, Revenue ($m), Historic, 2003-2010 37
Figure 19: Hydrocephalus Shunts, Brazil, Revenue ($m), Forecast, 2010-2017 38
Figure 20: Hydrocephalus Shunts, Brazil, Volume (Units), Historic, 2003-2010 39
Figure 21: Hydrocephalus Shunts, Brazil, Volume (Units), Forecast, 2010-2017 40
Figure 22: CSF Management, Brazil, Company Share (%), 2010 43
Figure 23: CSF Management, Russian Federation, Overall Revenue ($m), 2003-2017 45
Figure 24: CSF Management, Russian Federation, Revenue ($m), Historic, 2003-2010 46
Figure 25: CSF Management, Russian Federation, Revenue ($m), Forecast, 2010-2017 48
Figure 26: CSF Management, Russian Federation, Overall Volume (Units), 2003-2017 49
Figure 27: CSF Management, Russian Federation, Volume (Units), Historic, 2003-2010 50
Figure 28: CSF Management, Russian Federation, Volume (Units), Forecast, 2010-2017 52
Figure 29: Dura Substitutes, Russian Federation, Revenue ($m), Historic, 2003-2010 53
Figure 30: Dura Substitutes, Russian Federation, Revenue ($m), Forecast, 2010-2017 54
Figure 31: Dura Substitutes, Russian Federation, Volume (Units), Historic, 2003-2010 55
Figure 32: Dura Substitutes, Russian Federation, Volume (Units), Forecast, 2010-2017 56
Figure 33: Hydrocephalus Shunts, Russian Federation, Revenue ($m), Historic, 2003-2010 58
Figure 34: Hydrocephalus Shunts, Russian Federation, Revenue ($m), Forecast, 2010-2017 59
Figure 35: Hydrocephalus Shunts, Russian Federation, Volume (Units), Historic, 2003-2010 60
Figure 36: Hydrocephalus Shunts, Russian Federation, Volume (Units), Forecast, 2010-2017 61
Figure 37: CSF Management, Russian Federation, Company Share (%), 2010 64
Figure 38: CSF Management, India, Overall Revenue ($m), 2003-2017 65
Figure 39: CSF Management, India, Revenue ($m), Historic, 2003-2010 66
Figure 40: CSF Management, India, Revenue ($m), Forecast, 2010-2017 68
Figure 41: CSF Management, India, Overall Volume (Units), 2003-2017 70
Figure 42: CSF Management, India, Volume (Units), Historic, 2003-2010 71
Figure 43: CSF Management, India, Volume (Units), Forecast, 2010-2017 72
Figure 44: Dura Substitutes, India, Revenue ($m), Historic, 2003-2010 73
Figure 45: Dura Substitutes, India, Revenue ($m), Forecast, 2010-2017 74
Figure 46: Dura Substitutes, India, Volume (Units), Historic, 2003-2010 75
Figure 47: Dura Substitutes, India, Volume (Units), Forecast, 2010-2017 76
Figure 48: Hydrocephalus Shunts, India, Revenue ($m), Historic, 2003-2010 78
Figure 49: Hydrocephalus Shunts, India, Revenue ($m), Forecast, 2010-2017 79
Figure 50: Hydrocephalus Shunts, India, Volume (Units), Historic, 2003-2010 80
Figure 51: Hydrocephalus Shunts, India, Volume (Units), Forecast, 2010-2017 81
Figure 52: CSF Management, India, Company Share (%), 2010 84
Figure 53: CSF Management, China, Overall Revenue ($m), 2003-2017 85
Figure 54: CSF Management, China, Revenue ($m), Historic, 2003-2010 86
Figure 55: CSF Management, China, Revenue ($m), Forecast, 2010-2017 88
Figure 56: CSF Management, China, Overall Volume (Units), 2003-2017 90
Figure 57: CSF Management, China, Volume (Units), Historic, 2003-2010 91
Figure 58: CSF Management, China, Volume (Units), Forecast, 2010-2017 92
Figure 59: Dura Substitutes, China, Revenue ($m), Historic, 2003-2010 93
Figure 60: Dura Substitutes, China, Revenue ($m), Forecast, 2010-2017 94
Figure 61: Dura Substitutes, China, Volume (Units), Historic, 2003-2010 95
Figure 62: Dura Substitutes, China, Volume (Units), Forecast, 2010-2017 96
Figure 63: Hydrocephalus Shunts, China, Revenue ($m), Historic, 2003-2010 98
Figure 64: Hydrocephalus Shunts, China, Revenue ($m), Forecast, 2010-2017 99
Figure 65: Hydrocephalus Shunts, China, Volume (Units), Historic, 2003-2010 100
Figure 66: Hydrocephalus Shunts, China, Volume (Units), Forecast, 2010-2017 101
Figure 67: CSF Management, China, Company Share (%), 2010 104
Figure 68: CSF Management, South Africa, Overall Revenue ($m), 2003-2017 106
Figure 69: CSF Management, South Africa, Revenue ($m), Historic, 2003-2010 107
Figure 70: CSF Management, South Africa, Revenue ($m), Forecast, 2010-2017 108
Figure 71: CSF Management, South Africa, Overall Volume(Units), 2003-2017 109
Figure 72: CSF Management, South Africa, Volume (Units), Historic, 2003-2010 110
Figure 73: CSF Management, South Africa, Volume (Units), Forecast, 2010-2017 111
Figure 74: Dura Substitutes, South Africa, Revenue ($m), Historic, 2003-2010 112
Figure 75: Dura Substitutes, South Africa, Revenue ($m), Forecast, 2010-2017 113
Figure 76: Dura Substitutes, South Africa, Volume (Units), Historic, 2003-2010 114
Figure 77: Dura Substitutes, South Africa, Volume (Units), Forecast, 2010-2017 115
Figure 78: Hydrocephalus Shunts, South Africa, Revenue ($m), Historic, 2003-2010 117
Figure 79: Hydrocephalus Shunts, South Africa, Revenue ($m), Forecast, 2010-2017 118
Figure 80: Hydrocephalus Shunts, South Africa, Volume (Units), Historic, 2003-2010 119
Figure 81: Hydrocephalus Shunts, South Africa, Volume (Units), Forecast, 2010-2017 120
Figure 82: CSF Management, South Africa, Company Share (%), 2010 123
Figure 83: Medtronic, Inc., Company Share (%), BRICS CSF Management Market, 2010 126
Figure 84: Integra LifeSciences Holdings Corporation, Company Share (%), BRICS CSF Management Market, 2010 128
Figure 85: B. Braun Melsungen AG, Company Share (%), BRICS CSF Management Market, 2010 130
Figure 86: Sophysa S.A., Company Share (%), BRICS CSF Management Market, 2010 132
Companies Mentioned
Medtronic, Inc.
Integra LifeSciences Holdings Corporation
B. Braun Melsungen AG
Sophysa S.A.
To order this report:
Pathology Industry: Cerebrospinal Fluid (CSF) Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Pathology Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article